Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "Journal of Clinical Oncology"

Add to list
- Journal Article
- A1
- open access
AUGMENT : a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

John P Leonard, Marek Trneny, Koji Izutsu, Nathan H Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner (UGent) , Adriana Scheliga, Grzegorz S Nowakowski, et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(14). p.1188-1199
Add to list
- Journal Article
- open access
Treatment of Ovarian Cancer With Intraperitoneal Platinum: Heating Up the Debate

Emiel A. De Jaeghere (UGent) , Félix Gremonprez (UGent) , Philippe Tummers (UGent) , Wouter Willaert (UGent) , Wim Ceelen (UGent) , Frédéric Amant and Hannelore Denys (UGent)

(2019) Journal of Clinical Oncology.
Add to list
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet Ost (UGent) , Dries Reynders (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Aurélie De Bruycker (UGent) , Bieke Lambert (UGent) , Louke Delrue (UGent) , Renée Bultijnck (UGent) , Tom Claeys, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(5). p.446-453
Add to list
- Conference Paper
- C3
Randomized, open-label, phase 2/3 study of daratumumab (DARA) with or without JNJ-63723283, an anti-PD-1 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM)

Jan Van Droogenbroeck, Philip Vlummens (UGent) , Noa Lavi, Ka Lung Wu, Jiayu Fu, Huaibao Feng, Robin L Carson, Wendy Crist, Jordan Schecter and Yael Cohen

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(15, suppl.).
Add to list
- Conference Paper
- C3
Prognostic significance of number versus location of positive mesenteric nodes in node positive colon cancer

Kozo Kataoka, Elke Debrie (UGent) , Manabu Shiozawa, Els Goetghebeur (UGent) and Wim Ceelen (UGent)

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(15, suppl.).
Add to list
- Conference Paper
- C3
Role of ofatumumab (OFA) maintenance treatment in relapsed chronic lymphocytic leukemia (CLL): Final analysis of PROLONG study.

Marinus Van Oers, Lukas Smolej, Mario Petrini, Fritz Offner, Sebastian Grosicki, Mark-David Levin, Jaclyn Davis, Tommaso Stefanelli, Hiya Banerjee, Petra Hoever, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(15, suppl.).
Add to list
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio, et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(20). p.2240-2250
Add to list
Distrust in the end-of-life care provided to a parent and long-term negative outcomes among bereaved adolescents : a population-based survey study

Kim Beernaert (UGent) , Ulrika Kreicbergs, Carl Johan Fürst, Tommy Nyberg, Gunnar Steineck and Tove Bylund-Grenklo

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(27). p.3136-3142
Add to list
- Conference Paper
- C3
Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab

Kelly Schats, Emily A Van Vre, Isolde Debyser, Arno Vandenbroeck, Yanina Jansen, Teofila Seremet, Koen Marien, Erik Fransen, Dorien Schrijvers, Wim Van Criekinge (UGent) , et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(suppl. 15).
Add to list
- Conference Paper
- C3
A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types

Bikash Verma, Philippe Georges Aftimos, Ahmad Awada, Jean -Pascal H Machiels, Jason B Brayer, David A Sallman, Tessa Kerre (UGent) , Kunle Odunsi, Caroline Lonez, David Edward Gilham, et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(suppl. 15).

Academic Bibliography

AUGMENT : a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Treatment of Ovarian Cancer With Intraperitoneal Platinum: Heating Up the Debate

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Randomized, open-label, phase 2/3 study of daratumumab (DARA) with or without JNJ-63723283, an anti-PD-1 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM)

Prognostic significance of number versus location of positive mesenteric nodes in node positive colon cancer

Role of ofatumumab (OFA) maintenance treatment in relapsed chronic lymphocytic leukemia (CLL): Final analysis of PROLONG study.

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Distrust in the end-of-life care provided to a parent and long-term negative outcomes among bereaved adolescents : a population-based survey study

Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab

A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types

Contents

Support

Contact